Safety Considerations of Cancer Nanomedicine—A Key Step toward Translation
Liu, Xiangsheng, Tang, Ivanna, Wainberg, Zev A., Meng, Huan
Published in Small (Weinheim an der Bergstrasse, Germany) (01.09.2020)
Published in Small (Weinheim an der Bergstrasse, Germany) (01.09.2020)
Get full text
Journal Article
Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial
Subbiah, Vivek, Lassen, Ulrik, Élez, Elena, Italiano, Antoine, Curigliano, Giuseppe, Javle, Milind, de Braud, Filippo, Prager, Gerald W, Greil, Richard, Stein, Alexander, Fasolo, Angelica, Schellens, Jan H M, Wen, Patrick Y, Viele, Kert, Boran, Aislyn D, Gasal, Eduard, Burgess, Paul, Ilankumaran, Palanichamy, Wainberg, Zev A
Published in The lancet oncology (01.09.2020)
Published in The lancet oncology (01.09.2020)
Get full text
Journal Article
Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600-Mutant Anaplastic Thyroid Cancer
Subbiah, Vivek, Kreitman, Robert J, Wainberg, Zev A, Cho, Jae Yong, Schellens, Jan H M, Soria, Jean Charles, Wen, Patrick Y, Zielinski, Christoph, Cabanillas, Maria E, Urbanowitz, Gladys, Mookerjee, Bijoyesh, Wang, Dazhe, Rangwala, Fatima, Keam, Bhumsuk
Published in Journal of clinical oncology (01.01.2018)
Published in Journal of clinical oncology (01.01.2018)
Get full text
Journal Article
Safety and Efficacy of Durvalumab (MEDI4736), an Anti-Programmed Cell Death Ligand-1 Immune Checkpoint Inhibitor, in Patients With Advanced Urothelial Bladder Cancer
Massard, Christophe, Gordon, Michael S, Sharma, Sunil, Rafii, Saeed, Wainberg, Zev A, Luke, Jason, Curiel, Tyler J, Colon-Otero, Gerardo, Hamid, Omid, Sanborn, Rachel E, O'Donnell, Peter H, Drakaki, Alexandra, Tan, Winston, Kurland, John F, Rebelatto, Marlon C, Jin, Xiaoping, Blake-Haskins, John A, Gupta, Ashok, Segal, Neil H
Published in Journal of clinical oncology (10.09.2016)
Published in Journal of clinical oncology (10.09.2016)
Get full text
Journal Article
Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3 Randomized Clinical Trial
Shitara, Kohei, Van Cutsem, Eric, Bang, Yung-Jue, Fuchs, Charles, Wyrwicz, Lucjan, Lee, Keun-Wook, Kudaba, Iveta, Garrido, Marcelo, Chung, Hyun Cheol, Lee, Jeeyun, Castro, Hugo Raul, Mansoor, Wasat, Braghiroli, Maria Ignez, Karaseva, Nina, Caglevic, Christian, Villanueva, Luis, Goekkurt, Eray, Satake, Hironaga, Enzinger, Peter, Alsina, Maria, Benson, Al, Chao, Joseph, Ko, Andrew H, Wainberg, Zev A, Kher, Uma, Shah, Sukrut, Kang, S Peter, Tabernero, Josep
Published in JAMA oncology (01.10.2020)
Published in JAMA oncology (01.10.2020)
Get more information
Journal Article
Pembrolizumab alone or in combination with chemotherapy as first-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma: results from the phase II nonrandomized KEYNOTE-059 study
Bang, Yung-Jue, Kang, Yoon-Koo, Catenacci, Daniel V., Muro, Kei, Fuchs, Charles S., Geva, Ravit, Hara, Hiroki, Golan, Talia, Garrido, Marcelo, Jalal, Shadia I., Borg, Christophe, Doi, Toshihiko, Yoon, Harry H., Savage, Mary J., Wang, Jiangdian, Dalal, Rita P., Shah, Sukrut, Wainberg, Zev A., Chung, Hyun Cheol
Published in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (01.07.2019)
Published in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (01.07.2019)
Get full text
Journal Article
Phase III Trial of Avelumab Maintenance After First-Line Induction Chemotherapy Versus Continuation of Chemotherapy in Patients With Gastric Cancers: Results From JAVELIN Gastric 100
Moehler, Markus, Dvorkin, Mikhail, Boku, Narikazu, Özgüroğlu, Mustafa, Ryu, Min-Hee, Muntean, Alina S, Lonardi, Sara, Nechaeva, Marina, Bragagnoli, Arinilda C, Coşkun, Hasan S, Cubillo Gracian, Antonio, Takano, Toshimi, Wong, Rachel, Safran, Howard, Vaccaro, Gina M, Wainberg, Zev A, Silver, Matthew R, Xiong, Huiling, Hong, Janet, Taieb, Julien, Bang, Yung-Jue
Published in Journal of clinical oncology (20.03.2021)
Published in Journal of clinical oncology (20.03.2021)
Get full text
Journal Article
Phase I, Dose-Escalation, Two-Part Trial of the PARP Inhibitor Talazoparib in Patients with Advanced Germline BRCA1/2 Mutations and Selected Sporadic Cancers
de Bono, Johann, Ramanathan, Ramesh K, Mina, Lida, Chugh, Rashmi, Glaspy, John, Rafii, Saeed, Kaye, Stan, Sachdev, Jasgit, Heymach, John, Smith, David C, Henshaw, Joshua W, Herriott, Ashleigh, Patterson, Miranda, Curtin, Nicola J, Byers, Lauren Averett, Wainberg, Zev A
Published in Cancer discovery (01.06.2017)
Published in Cancer discovery (01.06.2017)
Get full text
Journal Article
Phase II study evaluating 2 dosing schedules of oral foretinib (GSK1363089), cMET/VEGFR2 inhibitor, in patients with metastatic gastric cancer
Shah, Manish A, Wainberg, Zev A, Catenacci, Daniel V T, Hochster, Howard S, Ford, James, Kunz, Pamela, Lee, Fa-Chyi, Kallender, Howard, Cecchi, Fabiola, Rabe, Daniel C, Keer, Harold, Martin, Anne-Marie, Liu, Yuan, Gagnon, Robert, Bonate, Peter, Liu, Li, Gilmer, Tona, Bottaro, Donald P
Published in PloS one (14.03.2013)
Published in PloS one (14.03.2013)
Get full text
Journal Article
Assessment of Pembrolizumab Therapy for the Treatment of Microsatellite Instability-High Gastric or Gastroesophageal Junction Cancer Among Patients in the KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Clinical Trials
Chao, Joseph, Fuchs, Charles S, Shitara, Kohei, Tabernero, Josep, Muro, Kei, Van Cutsem, Eric, Bang, Yung-Jue, De Vita, Ferdinando, Landers, Gregory, Yen, Chia-Jui, Chau, Ian, Elme, Anneli, Lee, Jeeyun, Özgüroglu, Mustafa, Catenacci, Daniel, Yoon, Harry H, Chen, Erluo, Adelberg, David, Shih, Chie-Schin, Shah, Sukrut, Bhagia, Pooja, Wainberg, Zev A
Published in JAMA oncology (01.06.2021)
Published in JAMA oncology (01.06.2021)
Get more information
Journal Article
Ramucirumab and durvalumab for previously treated, advanced non–small-cell lung cancer, gastric/gastro-oesophageal junction adenocarcinoma, or hepatocellular carcinoma: An open-label, phase Ia/b study (JVDJ)
Bang, Yung-Jue, Golan, Talia, Dahan, Laetitia, Fu, Siqing, Moreno, Victor, Park, Keunchil, Geva, Ravit, De Braud, Filippo, Wainberg, Zev A., Reck, Martin, Goff, Laura, Laing, Naomi, Mi, Gu, Oliveira, Joana M., Wasserstrom, Heather, Lin, Chia-Chi
Published in European journal of cancer (1990) (01.09.2020)
Published in European journal of cancer (1990) (01.09.2020)
Get full text
Journal Article
Improved Efficacy and Reduced Toxicity Using a Custom-Designed Irinotecan-Delivering Silicasome for Orthotopic Colon Cancer
Liu, Xiangsheng, Jiang, Jinhong, Chan, Ryan, Ji, Ying, Lu, Jianqin, Liao, Yu-Pei, Okene, Michael, Lin, Joshua, Lin, Paulina, Chang, Chong Hyun, Wang, Xiang, Tang, Ivanna, Zheng, Emily, Qiu, Waveley, Wainberg, Zev A, Nel, Andre E, Meng, Huan
Published in ACS nano (22.01.2019)
Published in ACS nano (22.01.2019)
Get full text
Journal Article
A Phase II Randomized, Double‐Blind, Placebo‐Controlled Study of Simtuzumab or Placebo in Combination with Gemcitabine for the First‐Line Treatment of Pancreatic Adenocarcinoma
Benson, Al B., Wainberg, Zev A., Hecht, J. Randolph, Vyushkov, Dmitry, Dong, Hua, Bendell, Johanna, Kudrik, Fred
Published in The oncologist (Dayton, Ohio) (01.03.2017)
Published in The oncologist (Dayton, Ohio) (01.03.2017)
Get full text
Journal Article
Lapatinib in Combination With Capecitabine Plus Oxaliplatin in Human Epidermal Growth Factor Receptor 2-Positive Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma: TRIO-013/LOGiC--A Randomized Phase III Trial
Hecht, J Randolph, Bang, Yung-Jue, Qin, Shukui K, Chung, Hyun C, Xu, Jianming M, Park, Joon O, Jeziorski, Krzysztof, Shparyk, Yaroslav, Hoff, Paulo M, Sobrero, Alberto, Salman, Pamela, Li, Jin, Protsenko, Svetlana A, Wainberg, Zev A, Buyse, Marc, Afenjar, Karen, Houé, Vincent, Garcia, Agathe, Kaneko, Tomomi, Huang, Yingjie, Khan-Wasti, Saba, Santillana, Sergio, Press, Michael F, Slamon, Dennis
Published in Journal of clinical oncology (10.02.2016)
Published in Journal of clinical oncology (10.02.2016)
Get full text
Journal Article
Bemarituzumab in patients with FGFR2b-selected gastric or gastro-oesophageal junction adenocarcinoma (FIGHT): a randomised, double-blind, placebo-controlled, phase 2 study
Wainberg, Zev A, Enzinger, Peter C, Kang, Yoon-Koo, Qin, Shukui, Yamaguchi, Kensei, Kim, In-Ho, Saeed, Anwaar, Oh, Sang Cheul, Li, Jin, Turk, Haci Mehmet, Teixeira, Alexandra, Borg, Christophe, Hitre, Erika, Udrea, Adrian A, Cardellino, Giovanni Gerardo, Sanchez, Raquel Guardeño, Collins, Helen, Mitra, Siddhartha, Yang, Yingsi, Catenacci, Daniel V T, Lee, Keun-Wook
Published in The lancet oncology (01.11.2022)
Published in The lancet oncology (01.11.2022)
Get full text
Journal Article
Evaluation of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Kinase Inhibitor, in Patients With Advanced Solid Tumors Harboring Genetic Alterations in Fibroblast Growth Factor Receptors: Results of a Global Phase I, Dose-Escalation and Dose-Expansion Study
Nogova, Lucia, Sequist, Lecia V, Perez Garcia, Jose Manuel, Andre, Fabrice, Delord, Jean-Pierre, Hidalgo, Manuel, Schellens, Jan H M, Cassier, Philippe A, Camidge, D Ross, Schuler, Martin, Vaishampayan, Ulka, Burris, Howard, Tian, G Gary, Campone, Mario, Wainberg, Zev A, Lim, Wan-Teck, LoRusso, Patricia, Shapiro, Geoffrey I, Parker, Katie, Chen, Xueying, Choudhury, Somesh, Ringeisen, Francois, Graus-Porta, Diana, Porter, Dale, Isaacs, Randi, Buettner, Reinhard, Wolf, Jürgen
Published in Journal of clinical oncology (10.01.2017)
Published in Journal of clinical oncology (10.01.2017)
Get full text
Journal Article
Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial
Padrón, Lacey J, Maurer, Deena M, O'Hara, Mark H, O'Reilly, Eileen M, Wolff, Robert A, Wainberg, Zev A, Ko, Andrew H, Fisher, George, Rahma, Osama, Lyman, Jaclyn P, Cabanski, Christopher R, Yu, Jia Xin, Pfeiffer, Shannon M, Spasic, Marko, Xu, Jingying, Gherardini, Pier Federico, Karakunnel, Joyson, Mick, Rosemarie, Alanio, Cécile, Byrne, Katelyn T, Hollmann, Travis J, Moore, Jonni S, Jones, Derek D, Tognetti, Marco, Chen, Richard O, Yang, Xiaodong, Salvador, Lisa, Wherry, E John, Dugan, Ute, O'Donnell-Tormey, Jill, Butterfield, Lisa H, Hubbard-Lucey, Vanessa M, Ibrahim, Ramy, Fairchild, Justin, Bucktrout, Samantha, LaVallee, Theresa M, Vonderheide, Robert H
Published in Nature medicine (01.06.2022)
Published in Nature medicine (01.06.2022)
Get full text
Journal Article